Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial

被引:7
|
作者
de Boniface, Jana [1 ,2 ]
Altena, Renske [3 ,4 ]
Ringborg, Cecilia Haddad [5 ]
Bolam, Kate A. [5 ]
Wengstrom, Yvonne [5 ,6 ]
机构
[1] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Capio St Gorans Hosp, Dept Surg, Stockholm, Sweden
[3] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
[5] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Nursing, Stockholm, Sweden
[6] Karolinska Univ Hosp, Karolinska Comprehens Canc Ctr, Stockholm, Sweden
来源
PLOS ONE | 2022年 / 17卷 / 10期
基金
瑞典研究理事会;
关键词
WEEKLY PACLITAXEL; MECHANISMS;
D O I
10.1371/journal.pone.0274804
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction In early breast cancer, neoadjuvant chemotherapy (NACT) is increasingly used. The proof of efficacy is pathologically complete response (pCR), i.e. the absence of invasive tumour in breast and lymph nodes at surgery. Today, pCR is a common endpoint in pharmaceutical trials since it is significantly associated with survival especially in triple-negative and HER2-positive subtypes. Apart from the mitigation of treatment-related toxicity and symptoms, physical exercise mediates anti-tumoral systemic effects associated with tumour regression in preclinical and clinical models. The aim of Neo-ACT is to test the hypothesis that physical exercise can improve pCR rates in breast cancer patients receiving NACT. Method The Neo-ACT trial is a prospective clinical trial, randomising T1-3N0-2 breast cancer patients planned for NACT to either a home-based physical exercise intervention supported by a mobile application or routine care. The primary endpoint is pCR; secondary endpoints are patient-reported quality of life, toxicity-related outcomes, and oncological outcomes such as Residual Cancer Burden, objective radiological tumour response, as well as overall, breast cancer-specific and disease-free survival at 2, 5 and 10 years. The intervention consists of a combination of high-intensity interval and resistance training of progressing intensity, and includes at least 150 min of moderate to vigorous physical activity per week, inclusive of two weekly 60-min exercise sessions. In order to show an improvement in pCR of 10%, a total of 712 participants need to be included in the analysis. The Neo-ACT has been registered at clinicaltrials.gov on January 11, 2022 (NCT05184582). Expected results If Neo-ACT can prove the oncological efficacy of physical exercise, implementation of training programmes into NACT schedules will be pursued. The use of a digitally led exercise intervention aims to test the potential of such a strategy for use in rural areas and areas of limited resources.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: the randomized Neo-ACT trial
    de Boniface, Jana
    Ringborg, Cecilia Haddad
    Altena, Renske
    Wengstrom, Yvonne
    CANCER RESEARCH, 2024, 84 (09)
  • [2] Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial
    Omodei, Michelle Sako
    Chimicoviaki, Jackeline
    Buttros, Daniel Araujo Brito
    Almeida-Filho, Benedito Souza
    Carvalho-Pessoa, Carla Priscila
    Carvalho-Pessoa, Eduardo
    Vespoli, Heloisa De Luca
    Nahas, Eliana Aguiar Petri
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2025,
  • [3] A New Pathological Response Index (PRI) for Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcomes of Locally Advanced Primary Breast Cancer (LABC)
    Abdel-Fatah, T. M. A.
    Mosely, P.
    Lee, A.
    Pinder, S.
    Reis-Filho, J. S.
    Ellis, I. O.
    Chan, S.
    JOURNAL OF PATHOLOGY, 2011, 224 : S3 - S3
  • [4] Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer
    Abdel-Fatah, Tarek M.
    Ball, Graham
    Lee, Andrew H. S.
    Pinder, Sarah
    MacMilan, R. Douglas
    Cornford, Eleanor
    Moseley, Paul M.
    Silverman, Rafael
    Price, James
    Latham, Bruce
    Palmer, David
    Chan, Arlene
    Ellis, Ian O.
    Chan, Stephen Y. T.
    CLINICAL CANCER RESEARCH, 2015, 21 (05) : 1052 - 1062
  • [5] Randomized trial of exercise and nutrition on pathological complete response among women with breast cancer receiving neoadjuvant chemotherapy: the Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) Study
    Ferrucci, Leah
    Sanft, Tara B.
    Harrigan, Maura
    Cartmel, Brenda
    Li, Fangyong
    Zupa, Michelle
    McGowan, Courtney
    Puklin, Leah
    Nguyen, Thai Hien
    Tanasijevic, Anna M.
    Neuhouser, Marian L.
    Hershman, Dawn
    Basen-Engquist, Karen
    Jones, Beth
    Knobf, Tish
    Chagpar, Anees B.
    Silber, Andrea L. M.
    Ligibel, Jennifer A.
    Irwin, Melinda L.
    CANCER RESEARCH, 2023, 83 (05)
  • [6] Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer
    Petersen, L. F.
    Jeruss, J. S.
    BREAST DISEASES, 2015, 26 (04): : 314 - 315
  • [7] Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer: A Randomized Pilot Trial
    Rao, Roshni
    Cruz, Veronica
    Peng, Yan
    Harker-Murray, Amy
    Haley, Barbara B.
    Zhao, Hong
    Xie, Xian-Jin
    Euhus, David
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2012, 6 : 39 - 46
  • [8] Neo-train: study protocol and feasibility results for a two-arm randomized controlled trial investigating the effect of supervised exercise during neoadjuvant chemotherapy on tumour response in patients with breast cancer
    Kjeldsted, Eva
    Ammitzboll, Gunn
    Jorgensen, Lars Bo
    Lodin, Alexey
    Bojesen, Rasmus Dahlin
    Ceballos, Silvia Gonzalez
    Rosthoj, Susanne
    Laenkholm, Anne-Vibeke
    Skou, Soren T.
    Jack, Sandy
    Gehl, Julie
    Dalton, Susanne Oksbjerg
    BMC CANCER, 2023, 23 (01)
  • [9] Neo-train: study protocol and feasibility results for a two-arm randomized controlled trial investigating the effect of supervised exercise during neoadjuvant chemotherapy on tumour response in patients with breast cancer
    Eva Kjeldsted
    Gunn Ammitzbøll
    Lars Bo Jørgensen
    Alexey Lodin
    Rasmus Dahlin Bojesen
    Silvia Gonzalez Ceballos
    Susanne Rosthøj
    Anne-Vibeke Lænkholm
    Søren T. Skou
    Sandy Jack
    Julie Gehl
    Susanne Oksbjerg Dalton
    BMC Cancer, 23
  • [10] Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial
    Morielli, Andria R.
    Usmani, Nawaid
    Boule, Normand G.
    Severin, Diane
    Tankel, Keith
    Nijjar, Tirath
    Joseph, Kurian
    Fairchild, Alysa
    Courneya, Kerry S.
    TRIALS, 2018, 19